Oxime-type acetylcholinesterase reactivators in pregnancy

An overview

Syed M. Nurulain, K. Tekes, Syed Naimul Hassan Naqvi, Charu Sharma, Shreesh Ojha, Abdu Adem

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Oxime-type acetylcholinesterase reactivators (oxime-AChER) are used as an adjunct in the treatment for organophosphorus anticholinesterase poisoning. Because of the widespread usage and exposure of organophosphorus compounds (OPCs), its poisoning and fatalities is obvious in pregnant women, embryos and fetuses. OPCs irreversibly inhibit acetylcholinesterase (AChE) at nerve synapses. Furthermore, the role of AChE other than neurotransmission termination has been defined in the literature. The growing evidences show that cholinergic mechanisms are involved during growth and development of other organ systems. In contrary to the fact, the data on the use of oxime-AChER in OPC poisoning in pregnancy are scanty. The present review aimed to comprehend the status of oximes in pregnancy in lieu of the published literature. A thorough literature search was performed in January 2013, using ten popular search engines including Medline/PubMed, Google scholar, etc., using nine standard keywords. The search period was set from 1966 to present. The search did not reveal substantial data. No considerable studies were retrieved which could really demonstrate either the beneficial, harmful or even null effect of oxime-AChER usage in pregnancy. Only eighteen relevant articles were obtained for a period of about 47 years. In the literature, there is no report available to demonstrate the risk of using oxime-AChER in pregnancy for the treatment of OPC poisoning. The study reveals that the use of oxime-AChER in pregnancy is largely un-addressed, inconclusive and based on speculation albeit the incidences of OPC poisoning are quite prevalent. Well-designed studies are warranted for a tangible conclusion.

Original languageEnglish
Pages (from-to)575-584
Number of pages10
JournalArchives of Toxicology
Volume88
Issue number3
DOIs
Publication statusPublished - Mar 2014

Fingerprint

Oximes
Acetylcholinesterase
Organophosphorus Compounds
Organophosphate Poisoning
Pregnancy
Search Engine
Cholinesterase Inhibitors
Search engines
Growth and Development
PubMed
Synaptic Transmission
Synapses
Poisoning
Cholinergic Agents
Pregnant Women
Fetus
Embryonic Structures
Incidence
Therapeutics

Keywords

  • Acetylcholine
  • Acetylcholinesterase reactivators
  • Fetus
  • Organophosphorus compound
  • Oximes
  • Pregnancy

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Cite this

Oxime-type acetylcholinesterase reactivators in pregnancy : An overview. / Nurulain, Syed M.; Tekes, K.; Naqvi, Syed Naimul Hassan; Sharma, Charu; Ojha, Shreesh; Adem, Abdu.

In: Archives of Toxicology, Vol. 88, No. 3, 03.2014, p. 575-584.

Research output: Contribution to journalArticle

Nurulain, SM, Tekes, K, Naqvi, SNH, Sharma, C, Ojha, S & Adem, A 2014, 'Oxime-type acetylcholinesterase reactivators in pregnancy: An overview', Archives of Toxicology, vol. 88, no. 3, pp. 575-584. https://doi.org/10.1007/s00204-013-1160-z
Nurulain, Syed M. ; Tekes, K. ; Naqvi, Syed Naimul Hassan ; Sharma, Charu ; Ojha, Shreesh ; Adem, Abdu. / Oxime-type acetylcholinesterase reactivators in pregnancy : An overview. In: Archives of Toxicology. 2014 ; Vol. 88, No. 3. pp. 575-584.
@article{f5859e4addf1452ba2cf2cc663947a29,
title = "Oxime-type acetylcholinesterase reactivators in pregnancy: An overview",
abstract = "Oxime-type acetylcholinesterase reactivators (oxime-AChER) are used as an adjunct in the treatment for organophosphorus anticholinesterase poisoning. Because of the widespread usage and exposure of organophosphorus compounds (OPCs), its poisoning and fatalities is obvious in pregnant women, embryos and fetuses. OPCs irreversibly inhibit acetylcholinesterase (AChE) at nerve synapses. Furthermore, the role of AChE other than neurotransmission termination has been defined in the literature. The growing evidences show that cholinergic mechanisms are involved during growth and development of other organ systems. In contrary to the fact, the data on the use of oxime-AChER in OPC poisoning in pregnancy are scanty. The present review aimed to comprehend the status of oximes in pregnancy in lieu of the published literature. A thorough literature search was performed in January 2013, using ten popular search engines including Medline/PubMed, Google scholar, etc., using nine standard keywords. The search period was set from 1966 to present. The search did not reveal substantial data. No considerable studies were retrieved which could really demonstrate either the beneficial, harmful or even null effect of oxime-AChER usage in pregnancy. Only eighteen relevant articles were obtained for a period of about 47 years. In the literature, there is no report available to demonstrate the risk of using oxime-AChER in pregnancy for the treatment of OPC poisoning. The study reveals that the use of oxime-AChER in pregnancy is largely un-addressed, inconclusive and based on speculation albeit the incidences of OPC poisoning are quite prevalent. Well-designed studies are warranted for a tangible conclusion.",
keywords = "Acetylcholine, Acetylcholinesterase reactivators, Fetus, Organophosphorus compound, Oximes, Pregnancy",
author = "Nurulain, {Syed M.} and K. Tekes and Naqvi, {Syed Naimul Hassan} and Charu Sharma and Shreesh Ojha and Abdu Adem",
year = "2014",
month = "3",
doi = "10.1007/s00204-013-1160-z",
language = "English",
volume = "88",
pages = "575--584",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Oxime-type acetylcholinesterase reactivators in pregnancy

T2 - An overview

AU - Nurulain, Syed M.

AU - Tekes, K.

AU - Naqvi, Syed Naimul Hassan

AU - Sharma, Charu

AU - Ojha, Shreesh

AU - Adem, Abdu

PY - 2014/3

Y1 - 2014/3

N2 - Oxime-type acetylcholinesterase reactivators (oxime-AChER) are used as an adjunct in the treatment for organophosphorus anticholinesterase poisoning. Because of the widespread usage and exposure of organophosphorus compounds (OPCs), its poisoning and fatalities is obvious in pregnant women, embryos and fetuses. OPCs irreversibly inhibit acetylcholinesterase (AChE) at nerve synapses. Furthermore, the role of AChE other than neurotransmission termination has been defined in the literature. The growing evidences show that cholinergic mechanisms are involved during growth and development of other organ systems. In contrary to the fact, the data on the use of oxime-AChER in OPC poisoning in pregnancy are scanty. The present review aimed to comprehend the status of oximes in pregnancy in lieu of the published literature. A thorough literature search was performed in January 2013, using ten popular search engines including Medline/PubMed, Google scholar, etc., using nine standard keywords. The search period was set from 1966 to present. The search did not reveal substantial data. No considerable studies were retrieved which could really demonstrate either the beneficial, harmful or even null effect of oxime-AChER usage in pregnancy. Only eighteen relevant articles were obtained for a period of about 47 years. In the literature, there is no report available to demonstrate the risk of using oxime-AChER in pregnancy for the treatment of OPC poisoning. The study reveals that the use of oxime-AChER in pregnancy is largely un-addressed, inconclusive and based on speculation albeit the incidences of OPC poisoning are quite prevalent. Well-designed studies are warranted for a tangible conclusion.

AB - Oxime-type acetylcholinesterase reactivators (oxime-AChER) are used as an adjunct in the treatment for organophosphorus anticholinesterase poisoning. Because of the widespread usage and exposure of organophosphorus compounds (OPCs), its poisoning and fatalities is obvious in pregnant women, embryos and fetuses. OPCs irreversibly inhibit acetylcholinesterase (AChE) at nerve synapses. Furthermore, the role of AChE other than neurotransmission termination has been defined in the literature. The growing evidences show that cholinergic mechanisms are involved during growth and development of other organ systems. In contrary to the fact, the data on the use of oxime-AChER in OPC poisoning in pregnancy are scanty. The present review aimed to comprehend the status of oximes in pregnancy in lieu of the published literature. A thorough literature search was performed in January 2013, using ten popular search engines including Medline/PubMed, Google scholar, etc., using nine standard keywords. The search period was set from 1966 to present. The search did not reveal substantial data. No considerable studies were retrieved which could really demonstrate either the beneficial, harmful or even null effect of oxime-AChER usage in pregnancy. Only eighteen relevant articles were obtained for a period of about 47 years. In the literature, there is no report available to demonstrate the risk of using oxime-AChER in pregnancy for the treatment of OPC poisoning. The study reveals that the use of oxime-AChER in pregnancy is largely un-addressed, inconclusive and based on speculation albeit the incidences of OPC poisoning are quite prevalent. Well-designed studies are warranted for a tangible conclusion.

KW - Acetylcholine

KW - Acetylcholinesterase reactivators

KW - Fetus

KW - Organophosphorus compound

KW - Oximes

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84896728144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896728144&partnerID=8YFLogxK

U2 - 10.1007/s00204-013-1160-z

DO - 10.1007/s00204-013-1160-z

M3 - Article

VL - 88

SP - 575

EP - 584

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

IS - 3

ER -